Healthcare group Mediclinic International Plc’s shares have been suspended from the London Stock Exchange (LSE), the Johannesburg Stock Exchange (JSE), and the Namibian Stock Exchange (NSX) on Friday.
This follows the group’s delisting from the LSE today, while the delisting of Mediclinic’s shares from the JSE and the NSX is expected to take effect from the commencement of trade on 7 June.
The company, which owns three hospitals in Namibia (in Windhoek, and at Swakopmund and Otjiwarongo), is being acquired by a consortium led by the Johannesburg-listed investment firm, Remgro Ltd.
According to British news agency Alliance News, Mediclinic accepted a sweetened offer from Manta Bidco Ltd, a consortium comprising Remgro and SAS Shipping Agencies Services Sarl, a subsidiary of MSC Mediterranean Shipping Co SA, in August last year.
Before the deal, Remgro held a 45% stake in Mediclinic.
This is the deal which has just been concluded.
On Friday, Mediclinic said the deal has become effective, meaning Bidco now owns the entire issued and to-be-issued share capital of the company.
It is intended that Mediclinic would shortly be re-registered as a private limited company.
Mediclinic is valued at GBP3,7 billion, or N$90 billion, and has over 70 hospitals globally.
Email: lazarus@namibian.com.na
Twitter: @Lasarus_A
Stay informed with The Namibian – your source for credible journalism. Get in-depth reporting and opinions for
only N$85 a month. Invest in journalism, invest in democracy –
Subscribe Now!
